Literature DB >> 206256

Response to several avian respiratory viruses as affected by infectious bursal disease virus.

J K Rosenberger, J Gelb.   

Abstract

After being inoculated with the infectious bursal disease virus (IBDV) at one day of age, specific-pathogen-free chickens were inoculated with either Newcastle disease virus (NDV), infectious bronchitis virus (IBV), or infectious laryngotracheitis virus (ILTV). Their immunity was challenged 2-3 weeks later with homologous virus, and antibody titers were determined for ILTV and IBV. Several studies were made to determine the effects of IBDV on the development of persistent or chronic virus infections. Chickens susceptible to IBDV were exposed to IBDV at one day and inoculated at two weeks of age with either NDV, IBV, or ILTV. Two, three, four, and five weeks postinoculation with the respiratory viruses, tracheal swabbings were collected for virus isolations. The birds were challenged with homologous virus at five weeks postinoculation. The results show that early (1-day) infections with IBDV affect the response of young birds to several avian respiratory viruses, as indicated by lowered resistance to challenge and humoral antibody levels for birds inoculated with ILTV and NDV. Birds infected with IBV and IBDV withstood IBV challenge but were much more prone to persistent infections than were birds not exposed to IBDV. High death rates and decreased weights in all IBDV-inoculated groups demonstrated the damaging effects of early IBDV infection.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 206256

Source DB:  PubMed          Journal:  Avian Dis        ISSN: 0005-2086            Impact factor:   1.577


  8 in total

1.  Infectious Bursal Disease Virus Activates c-Src To Promote α4β1 Integrin-Dependent Viral Entry by Modulating the Downstream Akt-RhoA GTPase-Actin Rearrangement Cascade.

Authors:  Chengjin Ye; Xinpeng Han; Zhaoli Yu; Enli Zhang; Lijuan Wang; Hebin Liu
Journal:  J Virol       Date:  2017-01-18       Impact factor: 5.103

2.  Correlation of hematological changes and serum and monocyte inhibition with the early suppression of phytohemagglutinin stimulation of lymphocytes in experimental infectious bursal disease.

Authors:  A W Confer; P S MacWilliams
Journal:  Can J Comp Med       Date:  1982-04

3.  Enzyme-linked immunosorbent assay-based detection of antibodies to antigenic subtypes of infectious bursal disease viruses of chickens.

Authors:  D J Jackwood; K S Henderson; R J Jackwood
Journal:  Clin Diagn Lab Immunol       Date:  1996-07

4.  Subclinical infectious bursal disease in commercial broiler flocks in Saskatchewan.

Authors:  L D Armstrong; H Tabel; C Riddell
Journal:  Can J Comp Med       Date:  1981-01

5.  Immunoreactivity and morphological changes of bursal follicles in chickens infected with vaccine or wild-type strains of the infectious bursal disease virus.

Authors:  Naoyuki Aihara; Noriyuki Horiuchi; Nanase Hikichi; Mariko Ochiai; Yuko Hosoda; Yoko Ishikawa; Yoko Shimazaki; Koji Oishi
Journal:  J Vet Med Sci       Date:  2015-05-10       Impact factor: 1.267

6.  Recombinant Lactococcus Expressing a Novel Variant of Infectious Bursal Disease Virus VP2 Protein Can Induce Unique Specific Neutralizing Antibodies in Chickens and Provide Complete Protection.

Authors:  Zhihao Wang; Jielan Mi; Yulong Wang; Tingting Wang; Xiaole Qi; Kai Li; Qing Pan; Yulong Gao; Li Gao; Changjun Liu; Yanping Zhang; Xiaomei Wang; Hongyu Cui
Journal:  Viruses       Date:  2020-11-25       Impact factor: 5.048

7.  Infectious bronchitis virus: Immunopathogenesis of infection in the chicken.

Authors:  G D Raj; R C Jones
Journal:  Avian Pathol       Date:  1997       Impact factor: 3.378

8.  Identification and assessment of pathogenicity of a naturally reassorted infectious bursal disease virus from Henan, China.

Authors:  Qiuxia Wang; Huilong Hu; Guangli Chen; Hailin Liu; Siyuan Wang; Dasong Xia; Yan Yu; Yanhong Zhang; Jinqing Jiang; Jinyou Ma; Yanzhao Xu; Zhiyong Xu; Changbo Ou; Xingyou Liu
Journal:  Poult Sci       Date:  2019-12-01       Impact factor: 3.352

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.